Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
2291 | 4567 | 24.6 | 61% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
8 | 4 | CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL | 1276458 |
259 | 3 | ANESTHESIOLOGY//PROPOFOL//BRITISH JOURNAL OF ANAESTHESIA | 44834 |
2291 | 2 | ROCURONIUM//VECURONIUM//SUGAMMADEX | 4567 |
343 | 1 | ROCURONIUM//SUGAMMADEX//VECURONIUM | 3617 |
20809 | 1 | END PLATE POTENTIAL//ICBAS PHARMACOL//H 3 ACETYLCHOLINE RELEASE | 444 |
22517 | 1 | CADMIUM INDUCED HYPERTENSION//MEMBRANE ACETYLCHOLINE RECEPTORS//POLYINOSITOL PHOSPHATES | 378 |
33138 | 1 | NICOTINIC ACETYLCHOLINE RECEPTORS PHEOCHROMOCYTOMA PC12 CELLS//PHARMACOL EXPTL MED//CATECHOLAMINE LEVEL | 128 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | ROCURONIUM | authKW | 950552 | 5% | 66% | 215 |
2 | VECURONIUM | authKW | 729352 | 3% | 70% | 156 |
3 | SUGAMMADEX | authKW | 667711 | 3% | 78% | 128 |
4 | ANESTHESIOLOGY | WoSSC | 572988 | 67% | 3% | 3056 |
5 | NEUROMUSCULAR BLOCK | authKW | 538507 | 3% | 69% | 116 |
6 | NEUROMUSCULAR RELAXANTS | authKW | 455563 | 2% | 80% | 85 |
7 | ATRACURIUM | authKW | 405165 | 2% | 70% | 86 |
8 | MIVACURIUM | authKW | 375775 | 2% | 71% | 79 |
9 | CISATRACURIUM | authKW | 352633 | 2% | 72% | 73 |
10 | NEUROMUSCULAR RELAXANTS VECURONIUM | authKW | 334093 | 1% | 88% | 57 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Anesthesiology | 572988 | 67% | 3% | 3056 |
2 | Critical Care Medicine | 2120 | 5% | 0% | 207 |
3 | Pharmacology & Pharmacy | 1850 | 14% | 0% | 641 |
4 | Veterinary Sciences | 86 | 3% | 0% | 122 |
5 | Physiology | 40 | 2% | 0% | 96 |
6 | Emergency Medicine | 17 | 0% | 0% | 20 |
7 | Chemistry, Medicinal | 10 | 1% | 0% | 58 |
8 | Medicine, General & Internal | 9 | 3% | 0% | 117 |
9 | Neurosciences | 7 | 4% | 0% | 168 |
10 | AGRICULTURAL EXPERIMENT STATION REPORTS | 4 | 0% | 0% | 1 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | GRP EXPT ANESTHESIOL CLIN PHARMACOL | 134794 | 0% | 92% | 22 |
2 | GRP EXPT ANAESTHESIOL CLIN PHARMACOL | 33421 | 0% | 100% | 5 |
3 | ANESTHESIOLNRG | 26737 | 0% | 100% | 4 |
4 | ICBAS PHARMACOL | 26733 | 0% | 67% | 6 |
5 | ANESTHESIOL | 20995 | 10% | 1% | 444 |
6 | ANESTHESIOL R370 | 13368 | 0% | 100% | 2 |
7 | MINIMAL INVAS GYNAECOL | 13368 | 0% | 100% | 2 |
8 | MOL PHARMACOL BIOL CHEM MPBC | 13368 | 0% | 100% | 2 |
9 | VICE DIRECTOR | 13368 | 0% | 100% | 2 |
10 | ANAESTHESIOL | 13021 | 3% | 2% | 131 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | BRITISH JOURNAL OF ANAESTHESIA | 291555 | 14% | 7% | 627 |
2 | ANESTHESIOLOGY | 134747 | 10% | 4% | 476 |
3 | ANESTHESIA AND ANALGESIA | 99377 | 10% | 3% | 466 |
4 | CANADIAN JOURNAL OF ANAESTHESIA-JOURNAL CANADIEN D ANESTHESIE | 65050 | 4% | 5% | 188 |
5 | ACTA ANAESTHESIOLOGICA SCANDINAVICA | 63144 | 6% | 4% | 253 |
6 | EUROPEAN JOURNAL OF ANAESTHESIOLOGY | 55915 | 3% | 5% | 159 |
7 | ANAESTHESIA | 44629 | 5% | 3% | 213 |
8 | CLINICS IN ANAESTHESIOLOGY | 21846 | 0% | 18% | 18 |
9 | ANAESTHESIST | 21838 | 3% | 3% | 119 |
10 | CANADIAN ANAESTHETISTS SOCIETY JOURNAL | 19919 | 1% | 6% | 47 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ROCURONIUM | 950552 | 5% | 66% | 215 | Search ROCURONIUM | Search ROCURONIUM |
2 | VECURONIUM | 729352 | 3% | 70% | 156 | Search VECURONIUM | Search VECURONIUM |
3 | SUGAMMADEX | 667711 | 3% | 78% | 128 | Search SUGAMMADEX | Search SUGAMMADEX |
4 | NEUROMUSCULAR BLOCK | 538507 | 3% | 69% | 116 | Search NEUROMUSCULAR+BLOCK | Search NEUROMUSCULAR+BLOCK |
5 | NEUROMUSCULAR RELAXANTS | 455563 | 2% | 80% | 85 | Search NEUROMUSCULAR+RELAXANTS | Search NEUROMUSCULAR+RELAXANTS |
6 | ATRACURIUM | 405165 | 2% | 70% | 86 | Search ATRACURIUM | Search ATRACURIUM |
7 | MIVACURIUM | 375775 | 2% | 71% | 79 | Search MIVACURIUM | Search MIVACURIUM |
8 | CISATRACURIUM | 352633 | 2% | 72% | 73 | Search CISATRACURIUM | Search CISATRACURIUM |
9 | NEUROMUSCULAR RELAXANTS VECURONIUM | 334093 | 1% | 88% | 57 | Search NEUROMUSCULAR+RELAXANTS+VECURONIUM | Search NEUROMUSCULAR+RELAXANTS+VECURONIUM |
10 | NEUROMUSCULAR BLOCKING AGENTS | 312532 | 2% | 43% | 109 | Search NEUROMUSCULAR+BLOCKING+AGENTS | Search NEUROMUSCULAR+BLOCKING+AGENTS |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | TUBA, Z , MAHO, S , VIZI, ES , (2002) SYNTHESIS AND STRUCTURE - ACTIVITY RELATIONSHIPS OF NEUROMUSCULAR BLOCKING AGENTS.CURRENT MEDICINAL CHEMISTRY. VOL. 9. ISSUE 16. P. 1507 -1536 | 184 | 96% | 33 |
2 | CHAMBERS, D , PAULDEN, M , PATON, F , HEIRS, M , DUFFY, S , CRAIG, D , HUNTER, J , WILSON, J , SCULPHER, M , WOOLACOTT, N , (2010) SUGAMMADEX FOR THE REVERSAL OF MUSCLE RELAXATION IN GENERAL ANAESTHESIA: A SYSTEMATIC REVIEW AND ECONOMIC ASSESSMENT.HEALTH TECHNOLOGY ASSESSMENT. VOL. 14. ISSUE 39. P. 1 -+ | 150 | 77% | 17 |
3 | SPARR, HJ , BEAUFORT, TM , FUCHS-BUDER, T , (2001) NEWER NEUROMUSCULAR BLOCKING AGENTS - HOW DO THEY COMPARE WITH ESTABLISHED AGENTS?.DRUGS. VOL. 61. ISSUE 7. P. 919 -942 | 148 | 93% | 37 |
4 | MERETOJA, OA , (2010) NEUROMUSCULAR BLOCK AND CURRENT TREATMENT STRATEGIES FOR ITS REVERSAL IN CHILDREN.PEDIATRIC ANESTHESIA. VOL. 20. ISSUE 7. P. 591-604 | 97 | 95% | 11 |
5 | BOOIJ, LHDJ , (1997) NEUROMUSCULAR TRANSMISSION AND ITS PHARMACOLOGICAL BLOCKADE .2. PHARMACOLOGY OF NEUROMUSCULAR BLOCKING AGENTS.PHARMACY WORLD & SCIENCE. VOL. 19. ISSUE 1. P. 13-34 | 163 | 82% | 4 |
6 | SCHALLER, SJ , LEWALD, H , (2016) CLINICAL PHARMACOLOGY AND EFFICACY OF SUGAMMADEX IN THE REVERSAL OF NEUROMUSCULAR BLOCKADE.EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY. VOL. 12. ISSUE 9. P. 1097 -1108 | 83 | 88% | 0 |
7 | BEVAN, DR , DONATI, F , KOPMAN, AF , (1992) REVERSAL OF NEUROMUSCULAR BLOCKADE.ANESTHESIOLOGY. VOL. 77. ISSUE 4. P. 785-805 | 137 | 88% | 119 |
8 | BRULL, SJ , MURPHY, GS , (2010) RESIDUAL NEUROMUSCULAR BLOCK: LESSONS UNLEARNED. PART II: METHODS TO REDUCE THE RISK OF RESIDUAL WEAKNESS.ANESTHESIA AND ANALGESIA. VOL. 111. ISSUE 1. P. 129-140 | 68 | 93% | 70 |
9 | ATHERTON, DPL , HUNTER, JM , (1999) CLINICAL PHARMACOKINETICS OF THE NEWER NEUROMUSCULAR BLOCKING DRUGS.CLINICAL PHARMACOKINETICS. VOL. 36. ISSUE 3. P. 169-189 | 97 | 99% | 30 |
10 | LIEN, CA , (2011) DEVELOPMENT AND POTENTIAL CLINICAL IMPAIRMENT OF ULTRA-SHORT-ACTING NEUROMUSCULAR BLOCKING AGENTS.BRITISH JOURNAL OF ANAESTHESIA. VOL. 107. ISSUE . P. 60-71 | 69 | 97% | 9 |
Classes with closest relation at Level 2 |